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The present work takes inspiration from the scientific degree plan of 
the Italian Ministry of Education and has a didactic and cultural 
character. It pursues three objectives: the first is to make young people 
understand the importance of mathematics in medicine; the second is 
to stimulate students to use mathematical tools to give rational 
answers in the therapeutic field, in particular in the treatment of some 
types of nodular tumors; the third is to inform people on the 
effectiveness of mathematical methods and their indispensability in 
the rigorous treatment of some human pathologies. 
Using the experimental data about the development of a tumor, we 
move on to the analysis of the mathematical models able to allow a 
rational control of its behavior. The method we used in the 
development of this therapeutic process is essentially deterministic, 
even if some passages implicitly have a probabilistic nature. 
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1.  Premise 
Usually, when we talk about the therapeutic treatment of serious pathologies 
it is difficult to consider the contribution of mathematics and statistics to the 
success of the interventions. Most often it is thought that positive results 
correspond to the abilities and knowledge of the luminaries of surgery and 
medicine. This article aims to provide additional information: to demonstrate 
that applied mathematics (in particular statistics) offers indispensable tools for 
a rational approach to these therapies. The method we used in the development 
of this therapeutic process is essentially deterministic, although some passages 
implicitly provide a probabilistic reference; in particular, when the least squares 
principle is applied for the research of the theoretical model of interpolation. 
The basic hypothesis is that the deviations of the experimental values from the 
theoretical values of the model have a Normal distribution. 
 
2.  Mathematics as a measure of the world 
The field in which Mathematics moves has become vast. Usually, it is 
divided into two major sectors: the pure and that applied mathematics. The first 
sector has a purely speculative nature and is concerned with a rigorous 
arrangement of the basic principles of the discipline; the second, instead, relates 
to the applications of mathematical methods to Natural Sciences, Medicine, 
Engineering and Economics. It is in this second sector that interesting 
applications can be found that can help man solve several technical-scientific 
problems. It is necessary, however, to warn this is only an exemplifying 
division. Actually, mathematics is a unitary whole and it is difficult to know 
where its theoretical part ends and its experimental soul begins and vice versa. 
Often, problems arise in an application environment that requires in-depth 
theoretical analysis. So, it is necessary to refer to an experience, to a useful 
operational path. 
A wider approach, not only descriptive, to natural phenomena requires a 
considerable knowledge of the mathematics that allows: 
- Their measurement (Analysis, Probability Calculus, Statistics); 
- The study of their possible forms (Analysis, Geometry, Statistics); 
- The coherent arrangement of the rules followed (Logic, Algebra). 
All scientific methodologies require compliance with these three points. 
 
3.  Problem analysis 
Biology is one of the sciences that is proving to be very ductile to use 
mathematical techniques for a rational response to problems. It enables, with 
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genetics good practices and good procedures to improve the lives of human 
beings. The mathematical fields that can be applied to Biology range from 
Combinatorial Calculus to Probability Calculus, to Geometry, to Statistics and 
they offer a vast set of procedures. 
The problem I am presenting is, certainly, of undoubted effect. It is an 
efficient and effective treatment to counteract, and eventually block, the 
progress of a particular type of tumor: the glioblastoma. It is a nodular tumor 
that lurks in the brain tissues and soon leads to the death of the host (the patient). 
We start from an experimental model of the tumor nodule, which, growing in 
the laboratory, gives us a lot of biological and kinetic measures of its growth 
(Figure 1). In particular, we can determine the growth time, the number of the 
cells for each instant of time and the critical limit of their growth beyond which 
there is nothing left to do (for example, for the compression of the tissues or for 
metastasis). In the dynamics of the tumor, we also consider the necrosis of many 
of its cells for the lack of food and of oxygen. It is also necessary to know the 
clinical picture of the patient and his immune response. 
After that, we analyze the mathematical models able to guarantee a rigorous 
control of the behavior of this type of tumor. 
 
4.  The choice of mathematical models 
On the basis of what we previously analyzed, the process requires the 
selection of mathematical models, as the first approach, in order to 
quantitatively describe the natural growth of the tumor mass over time and to 
find a mathematical model that allows to give to the patient a therapy that 
increases his life expectancy compared to the natural one, starting from the 
observation of the neoplasm. 
The mathematical models able to control the growth of biological 
populations are studied by that part of mathematics that is known as population 
dynamics [8]. When dealing with a problem of growth of biological populations, 
we take on known and tested standard models. Usually, any changes to be made 
to the models are arranged during the work, keeping the standard model used as 
fixed as possible. One of the most well-known growth models is that of Verhulst 
[8]. In our case, however, the Verhulst equation does not adapt well to describe 
the growth dynamics of the glioblastoma tumor cells. It has been observed, from 
previous studies, that the most suitable model to describe this growth is given 








Figure 1. Photomicrograph of an experimental tumor nodule (tumor spheroid). 
The reference bar is 400 µm long. The central area of the nodule, darker and 
denser, is mainly formed by dead cells because of the poor availability of oxygen 
and the accumulation of toxic substances produced by the cells themselves with 
their metabolism, due to problems related to the diffusion of these molecules in 
the tissue. This area is generally referred to as the necrotic heart. Photo courtesy 
of Dr Roberto Chignola, Department of Biotechnology, University of Verona. 
 
5.  Gompertz model and tumor growth 






   
𝑑𝑋(𝑡)
𝑑𝑡
= 𝑘𝑝(𝑡) ∙ 𝑋(𝑡)
    
𝑑𝑘𝑝(𝑡)
𝑑𝑡
= −𝛽 ∙ 𝑘𝑝(𝑡)  
                                                                                                         (1) 
 









]                                                                                   (2) 
 
Model (2) derives from (1), as can be demonstrated. 
We now present the parameters and variables of models (1) and (2). X (t) is 
the number of tumor cells at time t; K is the carrying capacity of the environment 
in which the tumor cells live and is equal to K = Max (X (t)): it represents the 
critical limit beyond which a tumor mass cannot go (otherwise would kill the 
host); X (t) / K is the occupancy rate of the environment; kp (t) is the time-
dependent growth rate of the tumor cell population;  𝛽 is a parameter that 
dampens the genetic growth of the population of individuals considered. 
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The differential equation (2) admits an integral curve in a closed form. It is 
given by: 
 
𝑋(𝑡) = 𝐾 ∙ 𝑒−𝐶∙𝑒
−𝛽∙𝑡
 .                                                                                                               (3) 
 
As shown, (3) depends on the parameters K, 𝛽, C. 






∙ 𝜋 ∙ 𝑟0
3           ,         𝑟0 =
1
2
∙ √𝑑𝑚𝑖𝑛 ∙ 𝑑𝑚𝑎𝑥   ,                                           (4) 
 
where Vol (t) is the volume of the tumor mass at time t, 𝑟0 is the geometric mean 
of the two rays dmin / 2 and dmax / 2, where dmin and dmax are the minimum and the 
maximum of the diameters of the spheroid. Once the volume is known, taking 
into account that a tumor cell has a known size (usually estimated in  10−9𝑐𝑚3), 
one can determine the number of cells in the nodule in the following way: 
 
𝑋(𝑡) = 𝑉𝑜𝑙(𝑡) 𝑉𝑜𝑙𝑐𝑒𝑙𝑙𝑢𝑙𝑎⁄ .                                                                                      (4bis) 
 
X (t) of (4bis) is a very large value and therefore not very useful for 
calculations. Since the volume of a cell is known and is constant, the size of the 
population of tumor cells is conveniently replaced by the volume of the tumor 
mass Vol (t). Starting from this substitution, X (t) becomes Vol (t) and, 
considering the multiplicative constant (1 / Volcellula), is also the population 
numerousness. 
It is now necessary to estimate the parameters of the model (3). 
 
6.  Discretization and parameter estimation 
The inevitable step to estimate the parameters of the model (2) or (3) with 
the least squares method is the discretization of the model. In practice, it consists 
to replacing the derivative with the incremental ratio and with the application of 









] ,                                                                                   (5) 
 




= 1 + 𝛽 ∙ 𝐿𝑜𝑔 (
𝐾
𝑋𝑡
) .                                                                                         (6) 
 
Equation (6) can be set in the following way: 
 
?̂?𝑡 = 𝐴 + 𝐵 ∙ 𝐿𝑜𝑔(𝑋𝑡) ,                     (7) 
     





Equation (7) is a linear model in the parameters. Thus we can apply the least 
squares method to estimate parameters A and B based on the experimental data 
in our possession. We obtain: 
 
𝑆(𝐴, 𝐵) =∑ (𝑌𝑗 − ?̂?𝑗)
2𝑛
𝑗=1
= ∑ (𝑌𝑗 − 𝐴 − 𝐵 ∙ 𝐿𝑜𝑔(𝑋𝑡))
2𝑛
𝑗=1
.                     (8) 
 
Passing to the partial derivatives with respect to A and to B, setting them 































.            (9) 
 
In this case, it is not necessary to proceed to the calculation of the second 
derivatives since the Hessian is a positive semidefinite matrix and therefore the 
solutions of the system (9) give precisely the minimum of S(A, B) [9]. 
Once we have found the values for A and B, β and K are easily obtained. It is 
then calculated 𝑋𝑡. For the calculation of the constant C in (3), the initial 
condition is taken into account: at time 𝑡 = 0 we have 𝑋(0) = 𝐾 ∙ 𝑒−𝐶, and 
hence we get 𝐶 = 𝐿𝑜𝑔𝐾 − 𝐿𝑜𝑔𝑋(0). 
 
7.  Processing 
To verify the validity of the method presented above, one uses the experi-
mental measurements daily obtained with glioblastoma tumor nodules grown in 
laboratory (spheroids). The measures are relative to the variations of nodular 
size, taken for 77 days. We start, therefore, from the set W of the experimental 
data, where the first term of each pair represents the discrete time expressed in 
days of each observation and the second the volume of the tumor mass expres-
sed in mm3: 
 
W= {{0, 3.57}, {1, 7.37}, {2, 10.9025},{3, 14.435},{4, 21.5},{5, 28.6}, 
{6, 37.14}, {7, 41.98}, {8, 52.89}, {9, 57.805},{10, 62.72},{11, 72.55}, 
{12, 88}, {13, 105.6}, {14, 96.5}, {15, 105.6},{16, 116.05},{17, 126.5}, 
{18, 147.4}, {19, 147.4}, {20, 185.2},{21, 172},{22, 199},{23, 199}, 
{24, 199}, {25, 199}, {26, 213.6}, {27, 199},{28, 199},{29, 199},{30, 199}, 
{31, 199}, {32, 199}, {33, 213.6}, {34, 199},{35, 213.6}, {36, 206.5}, 
{37, 199.4}, {38, 193}, {39, 185.2}, {40, 199}, {41, 199}, {42, 213.6}, 
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{43, 213.6}, {44, 213.6}, {45, 213.6}, {46, 213.6}, {47, 185.2}, {48, 213.6}, 
{49, 199}, {50, 213.6}, {51, 209.95}, {52, 206.3}, {53, 199}, {54, 199},  
{55, 213.6}, {56, 199}, {57, 199}, {58, 199}, {59, 199}, {60, 199}, 
{61, 213.6}, {62, 185.2}, {63, 185.2}, {64, 185.2}, {65, 185.2}, {66, 185.2}, 
{67, 213.6}, {68, 213.6}, {69, 199}, {70, 213.6}, {71, 203.2}, {72, 192.8}, {73, 
172}, {74, 199}, {75, 185.2},{76, 199}, {77, 199}}. 
 
From (9) we get: A = 1.93967, 𝛽  0.18076, K  180.991 mm3, X0 ≅ 3.57 
mm3, C ≅ 3.92588. 
It, therefore, turns out to be 
 
?̂?(𝑡) = 180.991 ∙ 𝑒−3.92588∙𝑒
−0.18076∙𝑡
 .                                                                            (10) 
 
It is not linear and therefore the goodness of fit is measured by the following 










 ,                                                                                        (11) 
 
where Xj are the second terms of the data pairs W, ?̂?𝑗 are the theoretical results 
of the application of (10), M is the average of the theoretical values ?̂?𝑗 and n is 
the sample size. 
In our case the value is 𝐼2 ≅ 0.147582. 
The value of I2 seems acceptable; moreover, given the difficulty of data 
collection, we can be satisfied with this approach even if, according to the 
international standard, a value lower than 0.1 should be recommended [10]. 
We now present the graph of the theoretical model and the distribution of 
experimental data around it (Figure 2). 
 
Figure 2. On the t-axis there is time in days, on the ordinates there is the volume 
of tumor. 
 
Calculating the second derivative of (10) and placing it equal to zero, we 
obtain the inflection point [7]. It is equal to (7.56578 days, 66.5829 mm3). We 





data. Let us now turn to the study of the optimal therapy to be applied to the 
nodule to control its growth. 
 
8.  The radiobiological treatment of tumor 
The goal of radiological treatment of the cancer is to reduce its mass by 
killing its cells, without simultaneously damaging healthy cells. Radiotherapies 
aim to achieve this goal. This treatment, however, is rather dangerous since, in 
the irradiation of the tumor mass, healthy tissue cells are unfortunately also 
affected. In short, the following problem must be addressed: how much mini-
mum radiant dose should be given to the patient to maximize the number of 
cancer cells killed with minimal damage to healthy cells? To answer this 
question, we need to address some preliminary aspects on the subject. 
We have shown that the Gompertz model is valid in the interpretation of the 
dynamics of the tumor mass of an experimental nodule of glioblastoma. At this 
point we apply the model also to evaluate the dynamic behavior of the same 
tumor in a patient. 
Before tackling the preliminaries, we consider that 𝑋0 = 𝐾 ∙ 𝑒
−𝑐 and we put 
it in (3), obtaining the following formula (algebraic steps are simple and are 
omitted): 
 




  ,                                                                                       (12) 
 
where 𝛼0 𝛽 = 𝐶⁄ , the parameter 𝛼0 assumes the meaning of instantaneous 
spheroid growth rate at time t = 0 and 𝛽 is a generic factor that deaden the 








= 𝑋0 ∙ 𝑒
𝛼0
𝛽 = 𝐾.                                     (13) 
 
Equation (13) represents a constraint on the growth of the spheroid. On the 
basis of a consolidated case series, it is believed that the maximum volume of 
the tumour borne by a patient can reach 25 cm3, after which the effects are 
devastating and lead to the death of the guest in a short time. Then from (13) we 
have: 
 
𝐿𝑜𝑔(𝐾) = 𝐿𝑜𝑔(𝑋0) +
𝛼0
𝛽










) ≅ 23.94,                                                               (14) 
 
where 𝑋0 in this case corresponds to the volume in cm
3 of a tumor cell at the 
beginning of the process; that is 𝑋0 = 𝑉𝑜𝑙𝑐𝑒𝑙𝑙𝑢𝑙𝑎. 
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9.  Some notions of radiobiology 
Often only possible therapy in the treatment of tumors is the radiotherapy, 
especially when the tumor involves important tissues of the human body or is 
located in places of difficult surgical access. From a clinical point of view, 
radiotherapy is an indispensable treatment even when it is considered necessary 
to intervene with more invasive therapies such as surgery and chemotherapy. 
Currently, biomedical research is further progressing with promising studies on 
the interaction between tumor cells and subatomic particles obtained with 
appropriate accelerators. At the moment encouraging results have been 
achieved, but the journey is still long. The treatment of tumor masses with 
radiation has the purpose of inducing massive molecular damage to the diseased 
cells so as to lead them to death. The decisive problem is to avoid as far as 
possible damage to healthy cells when one intervenes on sick cells. The damage 
induced by radiotherapy treatment depends on the intensity of the radiant dose. 
There are international indications that establish the effects of any radiation 
therapy. The radiant dose is expressed in Gray (Gy), which corresponds to the 
energy of 1 joule absorbed by 1 kg of biological tissue. Moreover, this basic unit 
must be multiplied by a suitable parameter that allows to take into account the 
effect on biological tissues of different nature of this radiant dose (RBE = 
Relative Biological Effectiveness). Finally, the product between Gy and RBE 
gives the equivalent biological dose to be administered, which is measured in 
Sievert (Sv). It should be considered that for radiations of clinical interest, 
radiation 𝛾 [4], we consider RBE = 1 and Gy = Sv. Table 1 highlights from a 
descriptive point of view the effects on human beings of exposure to radiant 
doses of different degrees of intensity [5]. 
 
Dose (Sv) Effects 
(0.05 - 0.2] No symptoms, but risk of DNA mutations 
(0.2 - 0.5] Temporary drop in red blood cells 
(0.5 - 1] Drop in immune system cells and risk of infection 
(1 - 2] Immunodepression, nausea and vomiting. Mortality of 10% at 30 
days from exposure 
(2 - 3] Severe immunodepression, nausea and vomiting 1-6 hours after 
exposure. Latency phase of 7-14 days after which symptoms appear 
such as hair loss. Mortality of 35% at 30 days from exposure 
(3 – 4] Bleeding of the mouth and urinary tract. Mortality of 50% at 30 
days from exposure 
(4 – 6] Mortality of 60% at 30 days from exposure. Female infertility. The 
convalescence lasts from a few months to a year 
(6 – 10] Complete injury of the bone marrow (the organ that produces red 
blood cells and all cells of the immune system). Symptoms appear 
between 15 and 30 minutes after exposure and mortality is 100% at 





(10 – 50] Immediate nausea, bleeding from the gastrointestinal tract and 
diarrhea, coma and death within 7 days. No medical intervention is 
possible 
(50 – 80] Immediate coma. Death occurs in a few hours due to the collapse 
of the nervous system 
> 80 Exposure to these doses occurred in two circumstances. 
Both subjects died within 49 hours of the accident 
Table 1: Effects of radiation on human beings 
 
10.  The modeling of therapy 
At this point, we must find a therapeutic process that allows us to stop the 
growth of the tumor or, even better, to reduce its mass to extinction. The model 
should take into account the disposition of the cells within the tumor mass, their 
microenvironment and the toxic effects induced on the healthy tissues of the 
surrounding cells and any other factor that may inform about the dynamics of 
the tumor. Studies conducted so far in various research institutes around the 
world have led to confirm, as an acceptable model to be considered in the 




,                                                                                      (15) 
 
where 𝑆?̂? is the survival rate, a and b are two arbitrary parameters and D is the 
radiant dose. We must estimate the parameters a and b of the model as a function 
of the experimental data. Even in this case we linearize the model and apply the 
least squares method. 
Dose (Gy) SF  Dose (Gy) SF 
0.0000 1.0000 5.5036 0.19609 
0.53957 0.87780 6.0072 0.18372 
1.0072 0.84048 6.5108 0.14785 
1.5468 0.73778 7.0144 0.11642 
2.0144 0.78746 7.5180 0.097850 
2.5180 0.62009 7.9856 0.073780 
3.0216 0.55627 8.4892 0.058100 
3.5252 0.46753 8.9928 0.043800 
3.9928 0.36816 9.4964 0.036020 
4.5324 0.33752 10.000 0.033750 
5.0360 0.26007 10.504 0.026010 
Table n. 2: Numerical data relating to the graph in figure 3, further on 
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11.  Assumptions for the radiotherapy 
When we face the problem of finding the relationship between a dynamic 
model of natural growth of a tumor and its radio-therapeutic treatment, collateral 
effects inevitably arise that create states other than those we would have liked 
to encounter. The complete modeling of a radiotherapy treatment requires the 
consideration of numerous variables that influence the interaction between 
tumor cells and radiant doses. For this reason, as a first approximation, we put 
some valid hypotheses to simplify the method. The choice of the hypotheses 
useful for the simplification of an effective model for the treatment of a tumor 
is in any case indispensable every time the control of the final results is desired. 
If we consider the analysis of the problem from a mathematical point of view, it 
is necessary to think about the implication of having to replace differential 
equations, defined in the continuous, with equivalent equations defined in the 
discrete. At this point we present the list of the necessary hypotheses to get on 
with the analysis of the process. 
Assumption 1: The Gompertz model is a good representation of the growth 
dynamic of a tumor mass, starting from a first degenerated cell up to 
asymptotically reaching a volume of 25 cm3. Thus, it is possible to simulate 
tumor growth using the equations (1), (2) and (3). 
Assumption 2: A solid tumor, in general, consists of proliferating cells P, 
quiescent cells Q and dead cells U. The number of total cells N at time t is 
therefore given by 
 
N(t) = P(t) + Q(t) + U(t).                  (16) 
 
Table 3 and Figure 5 refer only to proliferating cells since ionizing radiations 
are much less effective if directed against quiescent cells. 
Assumption 3: In a solid tumor, on an experimental basis, it is possible to 
state that the number of quiescent and dead cells becomes significant with 
respect to the total of cells at the inflection point of the Gompertz curve (3) and 
(12). 
Assumption 4: Radiation therapy has instantaneous effects, causing the 
immediate death of the cancer cells. These effects should at least be faster than 
the growth of tumor cells. This avoids a detailed kinetic analysis of the toxicity 
of radiation. 
Assumption 5: After undergoing radiotherapy treatment, the tumor grows 
with the same dynamic modalities that preceded the treatment. It is a common 
convention in scientific treatises; however, there are also different points of view 
on this matter [6]. 
Assumption 6: The maximum dose in a single treatment is 3 Gy. You can 
also perform multiple treatments if and only if they are repeated at 24-hour 





indicated by the radiotherapeutic protocols followed in the therapy of some 
tumors. The 3 Gy dose allows healthy tissues affected by radiation to recover 
from damage. 
Assumption 7: We assume the existence of two critical thresholds in the 
treatment phase: 1) if after treatment a tumor falls below 1 mm3, then we 
consider a therapy to be successful; 2) if, on the other hand, the volume increases 
beyond the dimension corresponding to the inflection point of the Gompertz 
curve, the therapy must be considered as failed. In practice, nothing justifies this 
assumption from a clinical or biological point of view and yet we accept it as 
work hypothesis. 
Based on these hypotheses, we can proceed with the estimation of the model 
parameters (15) and with the application of the programmed therapy. 
 
12.  Procedure for a rational therapy 
The method we will use for the treatment of glioblastoma, meets the 
following two objectives: 
1) Check if there is a relationship between the effectiveness of the radiotherapy 
treatment used and the rate of tumor growth. 
2) In case of an affirmative answer to the first objective, find a specific treatment 
protocol that allows to optimize the relationship between the benefits of the 
therapy and the costs due to the induction of toxic effects; in concrete terms, it 
is necessary to find the minimum amount of radiation to be used with the 
maximum destructive effect of cancer cells. 
We start with the estimation of the parameters of the model (15) using the 
well-known method of least squares and, also in this case, evaluating the 
goodness of fit with index I2 (11). The model (15) must be linearized: 
 
𝐿𝑜𝑔[𝑆?̂?(𝐷)] = −𝑎 ∙ 𝐷 − 𝑏 ∙ 𝐷2                                                                             (17) 
 
and applying the least squares method we have: 
 










Calculating the partial derivatives of S(a, b) with refer to a and to b, we obtain 
the system 
 
































                        (18) 
 
Considering the data in Table 2 and solving (18) with refer to a and b we 
obtain: 
 
𝑎 ≅ 0.124275;  𝑏 ≅ 0.0264028. 
 
The model adapted to the data in table 2 is, therefore: 
 
𝑆?̂?(𝐷) ≅ 𝑒−0.124275 𝐷−0.0264028 𝐷
2
                                                                (19) 
 










                                                      (20) 
 
and taking into account both the data in table 2, and the theoretical values 
calculated with (19), we get the goodness of fit: 𝐼2,𝑆𝐹 ≅ 0.0998765. This value 
shows that our approach is good. Figure 3 presents both the trend of 




Figure 3: the graph shows the link between the radiant dose and the fraction of 
surviving individuals (19). The points represent, in Cartesian coordinates, the 
data of table 2. We put on the D-axis the radiant dose, on the ordinate axis the 
survival rate SF(D). 
 
13.  Research of the inflection point 
At this point, it is necessary to start the therapy taking into account what has 
resulted from these preliminary procedures. We consider again the model (10) 
and figure 3. Furthermore, on the basis of the assumption 3, the most effective 






We consider the model (12): 
 




  ,                                                                                     (21) 
 
and taking into account that a cancer cell has a volume of 10−9 cm3 and that 
𝛽 = 0.016 we have: 
 
?̂?(𝑡) = 10−9 ∙ 𝑒23.9421 (1−𝑒
−0.016 𝑡)  .                                                                   (22) 
 
Calculating the second derivative of X(t) and setting it equal to zero we get 
the inflection point (198.477 days, 9.19654 cm3) [7]. We note that this result is 
different from that obtained using the model (10). Here, in fact, the parameters 
of the Gompertz model are changed, which are now imposed not by the 
experimental data of the single experimental nodule (which in our case led to 
the model (10)), but by a different operating standard that requires both a start 
from a single tumor cell, whose volume is fixed at 10 –9 cm3, and from a critical 
maximum limit of tumor expansion equal to 𝐾 ≅ 25 cm3. Figure 4 presents the 
function with the flex point. 
At this point the radiant doses should be applied at intervals that allow the 
patient's average life to be maximized. The first simulation (Fig. 4) considers a 
single-dose therapy to hit the tumor mass with a single dose of radiation (from 
1 to 3 Gy with intervals of 0.4). Starting at the time of the cancer diagnosis 
observation, when the tumor mass can vary from a minimum of 0.0050 cm3 to 
a maximum marked by the flex point, we have to measure the effect of the 
therapy on the cancer using the delay time of its growth. This time corresponds 
to the one that the tumor mass needs, after having been treated with 
radiotherapy, to return to the mass it had before the treatment was carried out. 
Methods and procedures are reported in [2]. In the last two graphs we report two 
other simulations in which, with respect to the protocol for the search for an 
optimal result, two different outcomes are observed. In figure 5, the result is not 
satisfactory; instead, in figure 6 the protocol gives a favorable outcome and the 
mass of the glioblastoma is reduced below the desired minimum threshold. 
 
 
Figure 4. Gompertz curve (22) related to the investigated tumor. The inflection 
point is (198.477 days, 9.19654 cm3). On the t-axis there is the time in days and 
on the ordinate axis the tumor volume in cm3. 
 







Figure 5. The graph 
describes the effect of 12 
radiotherapy treatments on 
a glioblastoma. The doses, 
in Gray, is (1, 2, 3, 1, 2, 0, 
0, 1, 2, 3, 1, 2). Note that 
the treatment did not give 
the desired result. The 
mass of the tumor has not 
been reduced below the 








Figure 6. The graph 
describes the effect of 12 
radiotherapy treatments 
on a glioblastoma. The 
doses, in Gray, is (2, 2, 3, 
3, 3, 0, 0, 2, 2, 3, 3, 3). In 
this case, it should be 
noted that the treatment 
has reached the desired 
result. The tumor mass 
was reduced under the 
critical threshold 




Each cusp corresponds to the flex point of the various curves that sequentially 
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